Syros Pharmaceuticals announced the appointment of Conley Chee as the company’s first Chief Commercial Officer. Mr. Chee brings 20 years of pharmaceutical sales leadership, marketing and strategy experience in the U.S. and globally, with particular expertise in driving commercial strategy for novel medicines for the treatment of cancer. Mr. Chee joins Syros from Novartis Pharmaceuticals, where he most recently served as Global Head of Portfolio Management, Global Pipeline Strategy and Precision Medicine. In this role, Mr. Chee had strategic responsibility for shaping Novartis’ overall pipeline, including driving commercial planning for the company’s early-stage portfolio and diagnostics strategy for oncology.